Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed (Daptacel)
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed is an FDA-licensed reference biologic from Sanofi Pasteur Limited. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2002
Reference approved
Reference product
Daptacel Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
Sanofi Pasteur Limited
- Approved
- May 14, 2002
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed, in chronological order.
Reference approval
Approval date of the reference Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed product.
24 yr 5 mo ago
Frequently asked questions
Are there biosimilars approved for Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed (Daptacel)?
No 351(k) biosimilars or interchangeable biosimilars referencing Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.